Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Canada has the science. Sunnybrook’s $41m bet asks if it has the trial infrastructure Canada has research strength but trial bottlenecks. Sunnybrook’s $41M gift may change how therapies reach patients faster. byPallavi MadhirajuApril 28, 2026